Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 91.27%-44.07K | -73.98%-619K | -56.23%16.08K | -65.05%-47.95K | 6.23%-82.36K | -83.13%-504.76K | 50.49%-355.79K | -98.51%36.73K | 99.03%-29.05K | -297.83%-87.83K |
| Net income from continuing operations | -964.71%-190.96K | 54.22%-431.75K | 50.44%-234.15K | 19.86%-99.48K | 7.23%-120.2K | 110.18%22.08K | 80.87%-943.07K | 70.35%-472.46K | 95.80%-124.14K | -6.13%-129.58K |
| Operating gains losses | --53.7K | 122.47%28.79K | ---- | ---- | ---- | ---- | -99.51%12.94K | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Asset impairment expenditure | --10.82K | -92.25%29.18K | ---- | ---- | ---- | --0 | -67.25%376.59K | ---- | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non cashItems | ---- | ---131.81K | --18.19K | --0 | --0 | ---150K | ---- | ---- | ---- | ---- |
| Change In working capital | 121.86%82.39K | -157.35%-113.41K | 45.47%174.07K | -45.81%51.53K | -9.35%37.85K | -541.57%-376.85K | -2.16%197.75K | 60.34%119.66K | 271.47%95.09K | -54.97%41.75K |
| -Change in receivables | --0 | -868.31%-19.2K | 145.61%7.68K | -196.81%-4.18K | -870.43%-17.25K | -142.64%-5.45K | -88.10%2.5K | 42.57%-16.85K | -88.27%4.32K | -92.79%2.24K |
| -Change in prepaid assets | --30.46K | -310.49%-22.1K | ---20.46K | ---1.64K | --0 | --0 | -85.37%10.5K | --0 | --0 | --0 |
| -Change in payables and accrued expense | 113.98%51.92K | -139.03%-72.1K | 36.88%186.85K | -36.82%57.35K | 39.45%55.1K | -352.79%-371.4K | 68.97%184.75K | 24.31%136.5K | 198.37%90.77K | -35.93%39.51K |
| Interest paid (cash flow from operating activities) | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 91.27%-44.07K | -73.98%-619K | -56.23%16.08K | -65.05%-47.95K | 6.23%-82.36K | -83.13%-504.76K | 50.49%-355.79K | -98.51%36.73K | 99.03%-29.05K | -297.83%-87.83K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 135.71%22.9K | 41.90%-36.14K | -136.13%-23.4K | 29,301.32%22.19K | 330.46%29.19K | -62.16%-64.12K | 43.00%-62.19K | 99.62%-9.91K | -100.00%-76 | 83.17%-12.67K |
| Net PPE purchase and sale | ---- | ---10K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | --88.09K | -63.05%15.27K | -139.46%-16.31K | ---- | ---- | --0 | --41.33K | -91.76%41.33K | ---- | ---- |
| Net other investing changes | -1.67%-65.19K | 60.00%-41.41K | 105.67%2.91K | -12,250.00%-9.39K | 330.46%29.19K | -62.16%-64.12K | 5.12%-103.52K | ---51.24K | ---76 | 65.80%-12.67K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 135.71%22.9K | 41.90%-36.14K | -136.13%-23.4K | 29,301.32%22.19K | 330.46%29.19K | -62.16%-64.12K | 43.00%-62.19K | 99.62%-9.91K | -100.00%-76 | 83.17%-12.67K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 105.47%644.88K | -8.24%-4.62K | 0 | 0 | 104.17%649.5K | -46.39%313.85K | -4.27K | 0 | 0 |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Net common stock issuance | --0 | 105.47%644.88K | -8.24%-4.62K | --0 | --0 | 104.17%649.5K | --313.85K | ---4.27K | --0 | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 105.47%644.88K | -8.24%-4.62K | --0 | --0 | 104.17%649.5K | -46.39%313.85K | ---4.27K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -28.62%25.59K | -74.39%35.85K | 182.12%37.54K | 49.16%63.3K | -18.52%116.47K | -74.39%35.85K | -63.37%139.98K | -95.07%13.31K | 103.64%42.44K | 8.83%142.93K |
| Current changes in cash | -126.25%-21.17K | 90.15%-10.26K | -153.01%-11.95K | 11.57%-25.76K | 47.09%-53.17K | 2,630.96%80.62K | 57.01%-104.13K | 117.33%22.54K | -111.69%-29.13K | 9.05%-100.5K |
| End cash Position | -96.20%4.42K | -28.62%25.59K | -28.62%25.59K | 182.12%37.54K | 49.16%63.3K | -18.52%116.47K | -74.39%35.85K | -74.39%35.85K | -95.07%13.31K | 103.64%42.44K |
| Free cash from | 91.27%-44.07K | -76.79%-629K | -83.46%6.08K | -65.05%-47.95K | 6.23%-82.36K | -83.13%-504.76K | 50.49%-355.79K | -98.51%36.73K | 99.03%-29.05K | -297.83%-87.83K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.